Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carmen Fernandez-Metzler

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Current Drug Metabolism|June 22, 2006
The use of Qtrap technology in drug metabolismRichard King, Carmen Fernandez-Metzler
Journal of Chromatography. A|August 30, 2002
Determination of chiral sulfoxides in plasma by normal-phase liquid chromatography-atmospheric pressure chemical ionization mass spectrometryCynthia Miller-Stein, Carmen Fernandez-Metzler
Bioanalysis|August 27, 2014
Applications of low-flow LC-SRM for the analysis of large molecules in pharmaceutical R&DMichael E Lassman, Carmen Fernandez-Metzler
Bioanalysis|October 6, 2016
Biomarkers and the sample matrix: challenges and opportunitiesRichard King, Carmen Fernandez-Metzler, Lorin M Bachmann
Journal of Pharmaceutical and Biomedical Analysis|June 22, 2005
Determination of potato carboxypeptidase inhibitor in African Green Monkey plasma using 96-well SPE and LC-MS/MSMark J Rose, Carmen Fernandez-Metzler, Brett A Johns, et al.
The AAPS Journal|May 5, 2022
Is Incurred Sample Reanalysis (ISR) Applicable in Biomarker Assays?Amanda Hays, Lakshmi Amaravadi, Carmen Fernandez-Metzler, et al.
Bioanalysis|August 12, 2025
Special consideration: commentary on the 2025 FDA Bioanalytical Method Validation for BiomarkersKaren J Quadrini, Jiri Aubrecht, Nicholas M P King, et al.
Bioorganic & Medicinal Chemistry Letters|March 5, 2005
Nonpeptide alpha(v)beta3 antagonists: identification of potent, chain-shortened 7-oxo RGD mimeticsAmy E Zartman, Le T Duong, Carmen Fernandez-Metzler, et al.
Bioorganic & Medicinal Chemistry|August 16, 2012
Riluzole prodrugs for melanoma and ALS: design, synthesis, and in vitro metabolic profilingMark E McDonnell, Matthew D Vera, Benjamin E Blass, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2004
Nonpeptide alpha V beta 3 antagonists. Part 9: Improved pharmacokinetic profile through the use of an aliphatic, des-amide backboneDavid B Whitman, Ben C Askew, Le T Duong, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Current Drug Metabolism|June 22, 2006
The use of Qtrap technology in drug metabolismRichard King, Carmen Fernandez-Metzler
Journal of Chromatography. A|August 30, 2002
Determination of chiral sulfoxides in plasma by normal-phase liquid chromatography-atmospheric pressure chemical ionization mass spectrometryCynthia Miller-Stein, Carmen Fernandez-Metzler
Bioanalysis|August 27, 2014
Applications of low-flow LC-SRM for the analysis of large molecules in pharmaceutical R&DMichael E Lassman, Carmen Fernandez-Metzler
Bioanalysis|October 6, 2016
Biomarkers and the sample matrix: challenges and opportunitiesRichard King, Carmen Fernandez-Metzler, Lorin M Bachmann
Journal of Pharmaceutical and Biomedical Analysis|June 22, 2005
Determination of potato carboxypeptidase inhibitor in African Green Monkey plasma using 96-well SPE and LC-MS/MSMark J Rose, Carmen Fernandez-Metzler, Brett A Johns, et al.
The AAPS Journal|May 5, 2022
Is Incurred Sample Reanalysis (ISR) Applicable in Biomarker Assays?Amanda Hays, Lakshmi Amaravadi, Carmen Fernandez-Metzler, et al.
Bioanalysis|August 12, 2025
Special consideration: commentary on the 2025 FDA Bioanalytical Method Validation for BiomarkersKaren J Quadrini, Jiri Aubrecht, Nicholas M P King, et al.
Bioorganic & Medicinal Chemistry Letters|March 5, 2005
Nonpeptide alpha(v)beta3 antagonists: identification of potent, chain-shortened 7-oxo RGD mimeticsAmy E Zartman, Le T Duong, Carmen Fernandez-Metzler, et al.
Bioorganic & Medicinal Chemistry|August 16, 2012
Riluzole prodrugs for melanoma and ALS: design, synthesis, and in vitro metabolic profilingMark E McDonnell, Matthew D Vera, Benjamin E Blass, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2004
Nonpeptide alpha V beta 3 antagonists. Part 9: Improved pharmacokinetic profile through the use of an aliphatic, des-amide backboneDavid B Whitman, Ben C Askew, Le T Duong, et al.
Pageof 3